Seasonal Affective Disorder Market Trends

Seasonal Affective Disorder Market report has valued the industry size at USD 0.85 billion in 2022 and is projected to grow from USD 0.88 Billion in 2023 to USD 1.15 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.5% during the forecast period (2023 - 2030).

Seasonal affective disorder (SAD) is a type of depression that is brought on by seasonal changes. It happens at the same time every year. Social disengagement, memory loss, weight gain, increased appetite, and melancholy are all common symptoms.

On the contrary, rising demand for light therapy and a growing market for generic pharmaceuticals may impede seasonal affective disorder market share growth.

Market Segmentation 

The MRFR report provides a complete segmental analysis of the seasonal affective disorder market report on the basis of type, treatment, diagnosis, and end user. 

Based on type, the seasonal affective disorder market is segmented into spring and summer SAD, fall and winter SAD, and others. 

Based on diagnosis, the seasonal affective disorder market is segmented into psychological evaluation, lab tests, physical exam, and others. The lab test segment is further segmented into thyroid blood tests, complete blood count, and others. The psychological evaluation segment is again segmented into direct observation tests, vocational tests, neuropsychological tests, aptitude tests, achievement tests, attitude tests, personality tests, and intelligence tests. 

Based on treatment, the seasonal affective disorder market is segmented into counselling, psychotherapy, medications, light therapy, and others. The medications segment has been further segmented into antidepressants and others. Antidepressants have been again segmented into reuptake inhibitors and others. The psychotherapy segment has further been segmented into gestalt therapy, existential psychotherapy, cognitive analytical therapy, body psychotherapy, behavioral therapy, attachment-based psychotherapy, art therapy, and others. 

Based on end user, the seasonal affective disorder market is segmented into medical research centers, academic institutes, hospitals and clinics, and others. 

Regional Analysis 

The seasonal affective disorder market report by region covers the most recent trends and potential possibilities in the Americas, Europe, Asia Pacific (APAC), the Middle East, and Africa (MEA). Over the forecast period, the Americas will lead the market. This is due to increased knowledge of various mental diseases and changes in lifestyle. This region's major contributors include the United States, South America, and Brazil.

The seasonal affective disorder market in Europe is expected to expand steadily over the projected period. This is because the prevalence of seasonal affective disorder and severe depression is increasing. The primary contributors in this region are the United Kingdom, Ireland, Germany, and France.

The APAC seasonal affective disorder market is expected to develop at the quickest rate during the projected period. This is due to increased awareness, changing lifestyles, the availability of products and treatments, and the development of health care facilities.

The Middle East and Africa seasonal affective disorder market share will develop slowly over the forecast period. This is due to a lack of healthcare facilities, a lack of understanding regarding seasonal affective disorder, and a low prevalence rate. Middle Eastern countries are leading the market due to increased health-care spending and strong healthcare infrastructure.

Key Players 

The global key players profiled in this seasonal affective disorder market outlook report include Pfizer Inc. (US), Henry Schein, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb Company (US), Bayer AG (Germany), Allergan (Republic of Ireland), and AbbVie Inc. (US). 

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: [email protected]

Website: https://www.marketresearchfuture.com